Antibody response to GroEL varies in patients with acute Mycoplasma pneumoniae infection
Related Experiment Video
Updated: Aug 19, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Dusan Bencina1, Brigita Slavec, Mojca Narat
1Department of Animal Sciences, Biotechnical Faculty, University of Ljubljana, 1230 Domzale, Slovenia.
Abstract:
Although heat-shock proteins represent major antigens in a wide spectrum of bacterial infections, their immunogenicity is not known for Mycoplasma pneumoniae. M. pneumoniae is a major human respiratory pathogen and it has been suggested that its groEL gene might be dispensable in vitro. Using the specific monoclonal antibody 2C2/C3 we found an abundant synthesis of about 58 kDa GroEL in M. pneumoniae reference strains and in 15 clinical isolates examined at low and higher passages. In patients with acute respiratory disease caused by M. pneumoniae immunoblot analyses showed relatively low prevalence of systemic antibodies against its GroEL protein. Whereas all patients had strong antibody response to the P1 adhesin, only 5 of 29 patients (17.2%) had antibodies to GroEL. Among them, patient RI raised an early and very strong antibody response to GroEL. During the convalescent phase, levels of his serum IgG (mainly IgG2) to GroEL increased and were higher than levels of IgG to P1.
Insights
Mycoplasma pneumoniae expresses abundant GroEL, a heat-shock protein. However, systemic antibodies against GroEL are rare in patients with M. pneumoniae respiratory infections, unlike antibodies to the P1 adhesin.
Area of Science:
- Microbiology
- Immunology
- Molecular Biology
Background:
- Heat-shock proteins are significant antigens in bacterial infections.
- The immunogenicity of heat-shock proteins in Mycoplasma pneumoniae infections is not well understood.
- Mycoplasma pneumoniae is a key pathogen causing human respiratory illness.
Purpose of the Study:
- To investigate the synthesis and immunogenicity of the GroEL protein in Mycoplasma pneumoniae.
- To determine the prevalence of antibodies against GroEL in patients with M. pneumoniae respiratory disease.
Main Methods:
- Utilized a specific monoclonal antibody (2C2/C3) to detect GroEL synthesis.
- Performed immunoblot analyses on patient sera to assess antibody responses.
- Examined reference strains and clinical isolates of M. pneumoniae.
Main Results:
- Abundant synthesis of ~58 kDa GroEL was confirmed in M. pneumoniae strains and clinical isolates.
- Low prevalence of systemic antibodies against GroEL was observed in patients with M. pneumoniae respiratory disease (17.2%).
- Antibody response to the P1 adhesin was strong in all patients, contrasting with the GroEL response.
Conclusions:
- Mycoplasma pneumoniae actively synthesizes GroEL.
- The GroEL protein of M. pneumoniae appears to have low immunogenicity in the context of acute respiratory infections.
- Further research is needed to understand the role of GroEL immunity in M. pneumoniae pathogenesis.
Related Concept Videos
Atypical Pneumonia
Pneumonia III: Complications and Assessment
Cross-reactivity